-+ 0.00%
-+ 0.00%
-+ 0.00%

Hunan Hi-Tech Industrial Investment Group reviews Hunan Gaochuang Xiangyu’s Changde base, urges year-end target push

PUBT·09/17/2026 07:24:11
Listen to the news
Hunan Hi-Tech Industrial Investment Group reviews Hunan Gaochuang Xiangyu’s Changde base, urges year-end target push
  • Hunan Pharmaceutical Development Private Equity Fund Management flagged an operating review at portfolio company Gaocreate Xiangyu’s Changde base on Sept. 16.
  • Management pressed Gaocreate Xiangyu to accelerate progress toward full-year targets, citing execution hurdles and tighter safety controls.
  • The group also called for faster upgrading, a reshaped business mix, stronger compliance, and tighter risk management to support longer-term growth.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunan Pharmaceutical Development Private Equity Fund Management Co Ltd published the original content used to generate this news brief on September 17, 2026, and is solely responsible for the information contained therein.